Products Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II Phase 3 Completed 📈 Rising Measles, Mumps, Rubella, Varicella
Mar 1, 1998 → Jun 1, 1999
About Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II is a phase 3 stage product being developed by Merck for Measles. The current trial status is completed. This product is registered under clinical trial identifier NCT00975507. Target conditions include Measles, Mumps, Rubella.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00975507 Phase 3 Completed Mar 1, 1998 Jun 1, 1999 Measles
Product Company Stage Hype Score Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified) Zydus Lifesciences Phase 3 MMRV (AMP) + MMRV (2006 process) Merck Phase 3 M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™ Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVV Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 ProQuad® manufactured with recombinant Human Albumin (rHA) Merck Phase 3 Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck) Merck Phase 3 measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks Merck Phase 3 V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine) Merck Phase 3 ProQuad® Merck Phase 3 MMR vaccine Merck Pre-clinical ProQuad® Merck Phase 3 ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: Placebo Merck Phase 3 Measles vaccine Novo Nordisk Approved Measles vaccine Novo Nordisk Approved Measles vaccine Novo Nordisk Approved
Other Products from Merck